AdvaMed Asks For Pre-Review Option For Patient-Reported Outcome Tools
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is urging FDA to pre-review sponsors' strategies for using patient-reported data to support product labeling claims before a clinical trial is initiated